Rachel Koreth, MBBS

Rachel Koreth practices at Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.

Rachel Koreth's NPI, 1922018480, was assigned on August 8, 2006. Rachel Koreth holds Minnesota license 43190.

Rachel Koreth's primary practice is Hennepin County Medical Center, at 701 Park Avenue, Minneapolis, MN 55415 in Hennepin County. The practice phone is (612) 873-3000.

Rachel Koreth's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County. The medical group on file is Hennepin Healthcare. Dmand AI also links Rachel Koreth to 1 more group practice or clinic, named with a free account. Rachel Koreth's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel Koreth practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rachel Koreth's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Rachel Koreth's licenses on file in 2 states: Minnesota and Louisiana.

CMS data shows 305 Medicare services from Rachel Koreth across 7 procedure codes in 2024, for 91 Medicare patients. Medicare paid $20,640 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Rachel Koreth in 2024. The largest group is 65 to 74, with 42 patients. 73% of them have high blood pressure, and 47% have cancer. 60% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachel Koreth's median patient age at 61, with 61% women.

In 2024, Rachel Koreth wrote 565 Medicare Part D claims for 100 patients. 76% of them were for generic drugs. CMS names the drug for 370 of them, across 18 drugs with 11 or more claims each, at $465,186 in total drug cost. In 2023, CMS named 399 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Rachel Koreth for performance year 2024, reported as part of a group. Rachel Koreth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rachel Koreth as offering telehealth.

CMS Open Payments shows 1 general payment to Rachel Koreth from 1 drug or device company in 2021. Education make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $12.